CEO Fennec Pharma Buys Big Block of Shares Amid Buzz, Investors Take Note.
Fennec Pharmaceuticals’ CEO buys 16,695 shares, signalling strong insider confidence and potential price stabilization amid biotech volatility.
4 minutes to read
Fennec Pharmaceuticals Inc
Fennec Pharma’s Chief Strategy Officer Exercises $19,000 Worth of Stock Options, Signaling Insider Confidence Amid Rising Sales and New Trials
Fennec’s insider buying: Cioffi’s 4,700‑share option exercise shows leadership’s confidence amid strong sales growth and a bolstered balance sheet.
3 minutes to read
Fennec CEO Settles 13,710 PSUs, Signaling Confidence as Share Price Climbs Past 52‑Week High
CEO Jeffrey Hackman’s recent 13,710‑share purchase signals growing confidence in Fennec Pharmaceuticals, amid a 7% weekly rally and strong insider buying.
4 minutes to read
CFO of Fennec Pharmaceuticals Buys More Shares Amid Market Dip, Reinforcing Long‑Term Confidence
Fennec Pharmaceuticals CFO’s latest insider buy signals long‑term confidence, hinting at a potential rebound amid market volatility and a strong oncology pipeline.
3 minutes to read